Hemocompatibility tests were conducted to evaluate safety
Retrieved from Milliman: Zhao, X., Wang, M., Wen, Z., Lu, Z., & Cui, L
A third person stops treatment after seeing results, only to watch improvements fade within months
Fecal microbiota transplantation in non-communicable diseases: recent advances and protocols
However, TRT alone does not address the concurrent decline in growth hormone or the tissue-repair demands of active patients
What began as a one-person operation with a vision to raise the standard for research materials has grown into a team of more than 25 people, all working toward the same goal: delivering premium-quality research products backed by transparency, rigorous testing, and uncompromising quality standards